“They never take into account the cost of research and development involved. They only want to pay for the cost of production.”
If you believe That whopper I got a nice bridge to sell you.
These numbers came out of a South Carolina Court decision on accusations JNJ/Risperdal defrauded their State Medicaid program.
“Annual Sales of Risperdal worldwide per annual reports of Johnson & Johnson, Inc.
1994: $0.172 Billion
1995: $0.343 Billion
1996: $0.502 Billion
1998: $0.588 Billion
1999: $0.892 Billion
2000: $1.083 Billion
2001: $1.845 Billion
2002: $2.146 Billion
2003: $2.512 Billion
2004: $3.05 Billion
2005: $3.552 Billion
2006: $4.180 Billion
2007: $4.697 Billion
2008: $1.309 Billion
2009: $1.425 Billion
2010: $1.50 Billion
Total for the period: $29.796 Billion
Testimony at trial indicated that the profit margin for sales of Risperdal was 97% or $28.90 Billion for the period of 1994-2010”
The problem with focusing on gross revenues is that it does not break out how much went to production costs, how much to regulatory costs, how much to salaries and benefits, how much rolled back into R&D, etc.
Showing only the gross revenues is usually a trick employed by leftists to “prove” that some company is engaging in exploitative and unfair profit.
That’s interesting but beside the point made thatt you replied to
Thst poster said foreign countries don’t want to pay for RD costs only production
Those increased sales don’t prove they do